Noninvasix is expected to be the first company to non-invasively monitor central venous oxygenation, an indicator of the severity of sepsis and septic shock, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real-time.
Noninvasix’s patented optoacoustic platform technology is the first solution designed to non-invasively and continuously measure central venous saturation.
Impact of Sepsis
Sepsis is a potentially life-threatening dysfunction that occurs when the body’s response to an infection damages its own tissues. When the infection-fighting processes turn on the body, they cause organs to function poorly and abnormally, and may progress to septic shock – a plunge in blood pressure that can lead to severe organ problems and death. Early treatment with antibiotics and IV fluids improves chances for survival.